Not Medicare Enrolled

Dr. Christina Cano-Gonzalez, M.D.

Family Medicine · San Benito, TX
Low-engagement
351 N SAM HOUSTON BLVD, San Benito, TX 78586
9563992443
In practice since 2005 (20 years)
NPI: 1548267180 verify on NPPES ↗
Moderate
DATA COVERAGE
Data in 2 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Cano-Gonzalez from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Cano-Gonzalez? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Cano-Gonzalez

Dr. Christina Cano-Gonzalez is a family medicine specialist in San Benito, TX, with 20 years of NPI registration.

Between the years covered by Open Payments, Dr. Cano-Gonzalez received a total of $4,913 from 27 pharmaceutical and/or device companies across 188 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in family medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Cano-Gonzalez is Moderate — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice $4,913 industry payments

Industry Payment Transparency

Open Payments through 2024 ↗
$4,913
Total received (2018-2024)
Avg $702/year across 7 years
Top 13% in TX for family medicine
27
Companies
188
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$4,893 (99.6%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$19 (0.4%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,349
2023
$677
2022
$214
2021
$566
2020
$450
2019
$857
2018
$800

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Novo Nordisk Inc
$1,545
Lilly USA, LLC
$969
AstraZeneca Pharmaceuticals LP
$698
Amarin Pharma Inc.
$431
Amgen Inc.
$177
Impulse Dynamics (USA) Inc.
$150
Mylan Specialty L.P.
$105
Boehringer Ingelheim Pharmaceuticals, Inc.
$96
GlaxoSmithKline, LLC.
$95
PFIZER INC.
$73
Merck Sharp & Dohme Corporation
$66
Astellas Pharma US Inc
$66
Janssen Pharmaceuticals, Inc
$65
Bayer Healthcare Pharmaceuticals Inc.
$55
SANOFI-AVENTIS U.S. LLC
$53
Abbott Laboratories
$38
Corcept Therapeutics
$37
Novartis Pharmaceuticals Corporation
$26
Biosense Webster, Inc.
$24
Phadia US Inc.
$23
Bayer HealthCare Pharmaceuticals Inc.
$21
Synergy Pharmaceuticals Inc
$20
AMAG Pharmaceuticals, Inc.
$19
IDORSIA PHARMACEUTICALS US INC
$18
Exact Sciences Corporation
$16
Hologic, LLC
$15
SI-BONE, Inc.
$12
Top 3 companies account for 65.4% of total payments
Associated products mentioned in payments ›
APTIMA · Aimovig · BREZTRI · BYDUREON · CARTO 3 · CHANTIX · Cologuard Collection Kit · EMGALITY · ENTRESTO · FARXIGA · FREESTYLE LIBRE 2 · FreeStyle Libre blood glucose Flash Monitoring System · INTRAROSA · ImmunoCAP · JANUVIA · JARDIANCE · Kerendia · Korlym · MOUNJARO · NUCALA · NURTEC ODT · Optimizer · Otezla · Ozempic · QUVIVIQ · RYBELSUS · Repatha · Rybelsus · SOLIQUA 100/33 · SYMBICORT · TRADJENTA · TRULICITY · Tresiba · Trulance · Vascepa · Veozah · Victoza · Wegovy · XARELTO · Xultophy 100/3.6 · Yupelri · iFuse Implant
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for a family medicine specialist in San Benito?
Compare family medicine physicians in the San Benito area by procedure volume, costs, and industry payment transparency.
Browse family medicine physicians nearby

Geographic Context

Family medicine physicians within 10 mi
127
Per 100K population
30.0
County median income
$51,334
Nearest hospital
RIO GRANDE STATE CENTER
8.7 mi

Data Sources

Provider Registry ✓ NPPES Weekly updates
Medicare Enrollment — Not enrolled N/A
Practice Data — No data N/A
Industry Payments ✓ Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 2 of 4 available federal datasets, with a Data Coverage level of Moderate. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Cano-Gonzalez is a family medicine specialist, with low-engagement industry engagement in the top 13% of TX peers, with 20 years of NPI registration.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Does Dr. Cano-Gonzalez receive payments from pharmaceutical companies?
Yes. Dr. Cano-Gonzalez received a total of $4,913 from 27 companies across 188 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
What does Data Coverage mean?
Data Coverage (currently Moderate for Dr. Cano-Gonzalez) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →

Explore related providers

Specialty guide
Understanding Family Medicine
Common procedures, typical costs, and what industry payments mean in family medicine.
Same specialty & city
Family Medicine Physicians in San Benito
Browse family medicine physicians in San Benito ranked by procedure volume and transparency data.
Highest volume
Top Family Medicine Physicians in TX
Family medicine physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Family Medicine Physicians in TX
Which TX family medicine physicians receive the most from drug and device companies.
By company
Novo Nordisk Inc Payments to Doctors
See all physicians who received payments from Novo Nordisk Inc.
By company
Lilly USA, LLC Payments to Doctors
See all physicians who received payments from Lilly USA, LLC.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →